Ecopetrol S.A. (EC)

NYQ – Real vaqt narxi. Valyuta: USD

13.08

+0.29 (2.27%)

Yopilishda: May 12, 2026, 4:00 PM EDT

12.95

-0.10 (-0.77%)

Bozor oldidan: May 13, 2026, 7:18 AM EDT

12.05.2026

Update from the Board of Directors of Ecopetrol S.A.

BOGOTA, Colombia, May 12, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) hereby announces that Mr.

12.05.2026

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

BOGOTA, Colombia, May 12, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) hereby announces that, within the framework of an investigation conducted by Colombia's General Prosecutor's Office (Fiscalía General de la Nación) against Ecopetrol's President, Ricardo Roa, such authority has formally charged Mr.

11.05.2026

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

BOGOTA, Colombia, May 11, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) hereby announces that it has duly registered with the Bogotá Chamber of Commerce the amendment to its Bylaws, as approved by the Company's General Shareholders' Meeting on November 11, 2025, and as set forth in Public Deed No.

06.05.2026

Ecopetrol publishes its year-end periodic report for fiscal year 2025

BOGOTA, Columbia, May 6, 2026 /PRNewswire/ -- Ecopetrol S.A (BVC: ECOPETROL; NYSE: EC) hereby announces that, in compliance with External Circulars No. 031 of 2021 and No.

06.05.2026

Moody's Downgrades Ecopetrol's Global Credit Rating to Ba2 and Affirms Its Stand‑Alone Credit Profile at b1

BOGOTA, Columbia, May 6, 2026 /PRNewswire/ -- Ecopetrol S.A (BVC: ECOPETROL; NYSE: EC) hereby informs that today, the credit rating agency Moody's Ratings downgraded the Company's global credit rating from Ba1 to Ba2 and revised the outlook from stable to negative. In contrast, the agency affirmed Ecopetrol's Baseline Credit Assessment (BCA), or stand‑alone credit profile, at b1, highlighting the Company's intrinsic strength.

29.04.2026

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--European Commission approves Henlius and Organon's POHERDY® (pertuzumab), the first approved Biosimilar to PERJETA (pertuzumab) in Europe.

29.04.2026

Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call

BOGOTA, Colombia, April 28, 2026 /PRNewswire/ -- Ecopetrol S.A (BVC: ECOPETROL; NYSE: EC) hereby announces that on Tuesday, May 12, 2026, it will release its financial and operational results for the first quarter of 2026, after market closes. On Wednesday, May 13, 2026, the company's management will hold a virtual earnings conference call, with simultaneous webcasts in Spanish and English, at the following times: Conference Call 09:00 a.m.

Videolar

No Data

There is no data to display

Press-relizlar

12.05.2026

Update from the Board of Directors of Ecopetrol S.A.

BOGOTA, Colombia, May 12, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) hereby announces that Mr.

12.05.2026

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

11.05.2026

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

06.05.2026

Ecopetrol publishes its year-end periodic report for fiscal year 2025

BOGOTA, Columbia, May 6, 2026 /PRNewswire/ -- Ecopetrol S.A (BVC: ECOPETROL; NYSE: EC) hereby announces that, in compliance with External Circulars No. 031 of 2021 and No.

Ecopetrol S.A. (EC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Ecopetrol S.A. (EC)

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Moody's Downgrades Ecopetrol's Global Credit Rating to Ba2 and Affirms Its Stand‑Alone Credit Profile at b1

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call

Videolar

No Data

Press-relizlar

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Moody's Downgrades Ecopetrol's Global Credit Rating to Ba2 and Affirms Its Stand‑Alone Credit Profile at b1

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call

Videolar

No Data

Press-relizlar

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Search stocks

Ecopetrol S.A. (EC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Ecopetrol S.A. (EC)

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Moody's Downgrades Ecopetrol's Global Credit Rating to Ba2 and Affirms Its Stand‑Alone Credit Profile at b1

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call

Videolar

No Data

Press-relizlar

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025

Moody's Downgrades Ecopetrol's Global Credit Rating to Ba2 and Affirms Its Stand‑Alone Credit Profile at b1

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call

Videolar

No Data

Press-relizlar

Update from the Board of Directors of Ecopetrol S.A.

Ecopetrol informs on decision by Colombia's General Prosecutor's Office

Ecopetrol S.A. Announces the Formalization of the Bylaws Amendment Approved by the General Shareholders' Meeting

Ecopetrol publishes its year-end periodic report for fiscal year 2025